These results support the hypothesis of the current study which was that participants would experience less social anxiety, general anxiety, and depression symptoms following the treatment.
Það dró marktækt úr félags- og almennum kvíða og þunglyndis einkennum og árangurinn viðhélst fjórum vikum seinna.